BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 32326425)

  • 1. Photobiomodulation for Parkinson's Disease in Animal Models: A Systematic Review.
    Salehpour F; Hamblin MR
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32326425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial photobiomodulation in the management of brain disorders.
    Montazeri K; Farhadi M; Fekrazad R; Akbarnejad Z; Chaibakhsh S; Mahmoudian S
    J Photochem Photobiol B; 2021 Aug; 221():112207. PubMed ID: 34119804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remote Photobiomodulation Treatment for the Clinical Signs of Parkinson's Disease: A Case Series Conducted During COVID-19.
    Liebert A; Bicknell B; Laakso EL; Jalilitabaei P; Tilley S; Kiat H; Mitrofanis J
    Photobiomodul Photomed Laser Surg; 2022 Feb; 40(2):112-122. PubMed ID: 34919459
    [No Abstract]   [Full Text] [Related]  

  • 4. Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson's Disease.
    Oueslati A; Lovisa B; Perrin J; Wagnières G; van den Bergh H; Tardy Y; Lashuel HA
    PLoS One; 2015; 10(10):e0140880. PubMed ID: 26484876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photobiomodulation Mitigates Cerebrovascular Leakage Induced by the Parkinsonian Neurotoxin MPTP.
    San Miguel M; Martin KL; Stone J; Johnstone DM
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31590236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvements in clinical signs of Parkinson's disease using photobiomodulation: a prospective proof-of-concept study.
    Liebert A; Bicknell B; Laakso EL; Heller G; Jalilitabaei P; Tilley S; Mitrofanis J; Kiat H
    BMC Neurol; 2021 Jul; 21(1):256. PubMed ID: 34215216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's Disease and Photobiomodulation: Potential for Treatment.
    Bicknell B; Liebert A; Herkes G
    J Pers Med; 2024 Jan; 14(1):. PubMed ID: 38276234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcranial photobiomodulation ameliorates midbrain and striatum neurochemical impairments and behavioral deficits in reserpine-induced parkinsonism in rats.
    Mohammed HS; Hosny EN; Sawie HG; Khadrawy YA
    Photochem Photobiol Sci; 2023 Dec; 22(12):2891-2904. PubMed ID: 37917308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-conditioning with Remote Photobiomodulation Modulates the Brain Transcriptome and Protects Against MPTP Insult in Mice.
    Ganeshan V; Skladnev NV; Kim JY; Mitrofanis J; Stone J; Johnstone DM
    Neuroscience; 2019 Feb; 400():85-97. PubMed ID: 30625333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Buckets": Early Observations on the Use of Red and Infrared Light Helmets in Parkinson's Disease Patients.
    Hamilton CL; El Khoury H; Hamilton D; Nicklason F; Mitrofanis J
    Photobiomodul Photomed Laser Surg; 2019 Oct; 37(10):615-622. PubMed ID: 31536464
    [No Abstract]   [Full Text] [Related]  

  • 11. Red and NIR light dosimetry in the human deep brain.
    Pitzschke A; Lovisa B; Seydoux O; Zellweger M; Pfleiderer M; Tardy Y; Wagnières G
    Phys Med Biol; 2015 Apr; 60(7):2921-37. PubMed ID: 25789711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration Profiles of Visible and Near-Infrared Lasers and Light-Emitting Diode Light Through the Head Tissues in Animal and Human Species: A Review of Literature.
    Salehpour F; Cassano P; Rouhi N; Hamblin MR; De Taboada L; Farajdokht F; Mahmoudi J
    Photobiomodul Photomed Laser Surg; 2019 Oct; 37(10):581-595. PubMed ID: 31553265
    [No Abstract]   [Full Text] [Related]  

  • 13. Mitochondrial Dysfunction and Parkinson's Disease-Near-Infrared Photobiomodulation as a Potential Therapeutic Strategy.
    Foo ASC; Soong TW; Yeo TT; Lim KL
    Front Aging Neurosci; 2020; 12():89. PubMed ID: 32308618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Neurodegeneration: Integrating Photobiomodulation and Neurofeedback in Alzheimer's Dementia and Parkinson's: A Review.
    Berman MH; Nichols TW
    Photobiomodul Photomed Laser Surg; 2019 Oct; 37(10):623-634. PubMed ID: 31647776
    [No Abstract]   [Full Text] [Related]  

  • 15. Transcranial and systemic photobiomodulation for major depressive disorder: A systematic review of efficacy, tolerability and biological mechanisms.
    Caldieraro MA; Cassano P
    J Affect Disord; 2019 Jan; 243():262-273. PubMed ID: 30248638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remote photobiomodulation targeted at the abdomen or legs provides effective neuroprotection against parkinsonian MPTP insult.
    Gordon LC; Martin KL; Torres N; Benabid AL; Mitrofanis J; Stone J; Moro C; Johnstone DM
    Eur J Neurosci; 2023 May; 57(9):1611-1624. PubMed ID: 36949610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photobiomodulation for Neurodegenerative Diseases: A Scoping Review.
    Shen Q; Guo H; Yan Y
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Photobiomodulation Therapy: a Narrative Review.
    Salehpour F; Mahmoudi J; Kamari F; Sadigh-Eteghad S; Rasta SH; Hamblin MR
    Mol Neurobiol; 2018 Aug; 55(8):6601-6636. PubMed ID: 29327206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Photobiomics": Can Light, Including Photobiomodulation, Alter the Microbiome?
    Liebert A; Bicknell B; Johnstone DM; Gordon LC; Kiat H; Hamblin MR
    Photobiomodul Photomed Laser Surg; 2019 Nov; 37(11):681-693. PubMed ID: 31596658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.